ArticleMolecular oncology2018

Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome.

Silvia Grassilli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.